Wednesday, April 18, 2012

Progressive Multifocal leukoencephalopathy (PML)

PML continues be a nemesis for the antibody based therapies. The new CD30 antibody, Brentuximab, has been associated with PML.

http://www.ncbi.nlm.nih.gov/pubmed/22472351
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)